Trial Profile
A retrospective study to evaluate the therapeutic drug monitoring of imatinib in patients with gastrointestinal stromal tumors.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 05 Oct 2015 New trial record